Added by | mollevi |
---|---|
Last modified by | llasorsa |
Group name | EquipeMY |
Item Type | Attachment |
Title | PubMed entry |
URL | http://www.ncbi.nlm.nih.gov/pubmed/33405269 |
Accessed | 2021/02/02 - 16:14:18 |
Date Added | 2021/02/02 - 15:14:18 |
Date Modified | 2024/10/10 - 16:34:21 |
Parent item | Phase II study evaluating the association of gemcitabine, trastuzumab and erlotinib as first-line treatment in patients with metastatic pancreatic adenocarcinoma (GATE 1) |